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ABSTRACT
Recent advances in technology have led to a
dramatic increase in the number of available tran-
scription factor ChIP-seq and ChIP-chip data sets.
Understanding the motif content of these data sets
is an important step in understanding the underlying
mechanisms of regulation. Here we provide a sys-
tematic motif analysis for 427 human ChIP-seq data
sets using motifs curated from the literature and
also discovered de novo using five established
motif discovery tools. We use a systematic
pipeline for calculating motif enrichment in each
data set, providing a principled way for choosing
between motif variants found in the literature and
for flagging potentially problematic data sets. Our
analysis confirms the known specificity of 41 of
the 56 analyzed factor groups and reveals motifs
of potential cofactors. We also use cell type-
specific binding to find factors active in specific
conditions. The resource we provide is accessible
both for browsing a small number of factors and
for performing large-scale systematic analyses. We
provide motif matrices, instances and enrichments
in each of the ENCODE data sets. The motifs dis-
covered here have been used in parallel studies to
validate the specificity of antibodies, understand
cooperativity between data sets and measure the
variation of motif binding across individuals and
species.
INTRODUCTION
Chromatin immunoprecipitation (ChIP) (1) followed by
hybridization to an array (ChIP-chip) (2,3) or sequencing
(ChIP-seq) (4) enables the genome-wide identiﬁcation of
the binding locations of transcription factors (TFs)
present in a given condition and cell type or tissue. As
these technologies have matured, their use has become
increasingly widespread. The resolution of these experi-
mental techniques can be as low as 300 bp for ChIP-chip
(5) and 50 bp for ChIP-seq (6), depending on the experi-
mental design (e.g. fragment size, paired-end sequencing)
and algorithmic processing of the raw data.
The use of these technologies on a variety of factors
across many cell types has increasingly highlighted the
complex nature of TF activity, often violating the simple
model of a factor binding to its recognition pattern (motif)
in isolation: binding has been shown to be dynamic across
cell types, requiring the coordinated binding of cofactors
or speciﬁc conﬁgurations of the underlying chromatin.
Moreover, TF binding frequently occurs in the absence
of any discernible motif instance (7,8) or to ‘hot-spots’
where several factors are simultaneously found (9).
Understanding this complex binding necessitates identify-
ing the underlying sequence features responsible. To
address this need, we have performed a systematic,
motif-centric analysis of hundreds of TF binding experi-
ments made available as part of the human ENCODE
project (8,10). As part of this, we provide a collection of
motifs for each assayed factor, both taken from the litera-
ture and through de novo discovery, and also an annota-
tion of motif instances genome-wide, which may be
used to pinpoint the speciﬁc regulatory bases in regions
bound by TFs.
We found that no single algorithm or database compre-
hensively assays the motifs relevant to the binding diver-
sity surveyed by ENCODE. Therefore, our approach was
to collect motifs from several literature sources (11–16)
and supplement them with motifs discovered de novo on
the data sets themselves using ﬁve established tools
(17–21). Although this general approach of using
multiple motif discovery tools is popular [e.g. (22–24)],
its application to this number of data sets is unprecedented
and permits the identiﬁcation of TFs that are likely to be
interacting or participating in common pathways.
*To whom correspondence should be addressed. Tel: +1 617 253 2419; Fax: +1 617 452 5034; Email: manoli@mit.edu
Nucleic Acids Research, 2013, 1–12
doi:10.1093/nar/gkt1249
 The Author(s) 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial
re-use, please contact journals.permissions@oup.com
 Nucleic Acids Research Advance Access published December 13, 2013
 at M
IT Libraries on February 12, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
This work is accompanied by a web interface for
browsing the discovered and literature motifs along with
their enrichments (Figure 1; http://compbio.mit.edu/
encode-motifs). In addition to the browsing interface, we
provide several data ﬁles including all motif matrices and
their matches to the genome, as well as software to
compute enrichments and perform uniﬁed motif discovery
with the ﬁve tools we use. Together, these permit both
analyses of individual factors (e.g. to identify cooperating
TFs) in addition to systematic analysis (e.g. to examine
differences between TFs). Moreover, the breadth of data
sets available enables systematic comparisons and
analyses that are not possible when only one or a few
factors are studied in isolation.
Later in the text, we describe the details of how the
resource was generated and conduct an initial analysis to
provide examples of its usage and to highlight potentially
interesting results.
MATERIALS AND METHODS
Our goals were to produce a resource that (i) contains a
comprehensive collection of relevant motifs for each
factor; (ii) avoids repetitive, weakly enriched motifs that
do not contribute to the in vivo speciﬁcity of the factor or
its partners; and (iii) excludes variants of the same motif,
particularly among the discovered motifs. With this in
mind, we conducted motif discovery separately on each
data set using ﬁve motif discovery tools and manually
placed all its data sets into ‘factor groups’ on the basis
of known motifs and homology (Figure 2). Known
motifs from the literature and the top 10 most enriched
discovered motifs (excluding duplicates) were collected for
each factor group (see Supplementary Methods) and
named as TF_known# for known motifs and TF_disc#
for discovered motifs, where TF denotes the factor
group (e.g. FOXA, CTCF, etc.). Known motifs were
ordered arbitrarily, whereas the discovered motifs were
ordered in descending order of the enrichment value that
was used for their selection.
The 427 ENCODE experiments analyzed correspond to
123 TFs, which we place into 84 factor groups (Figure 3a).
We failed to discover an enriched motif for only 12 of the
84 factor groups, of which 9 lack DNA binding domains
(BRF, CTBP2, HDAC8, KAT2A, NELFE, SUPT20H,
SUZ12, WRNIP1 and XRCC4) as identiﬁed by UniProt
(27), and 6 have all their data sets ﬂagged as unreliable
based on various quality metrics [BRF, KAT2A, NELFE,
NR4A, SUPT20H and ZZZ3; see (A. Kundaje, L.Y. Jung,
P.V. Kharchenko, B. Wold, A. Sidow, S. Batzoglou and
P.J. Park, in preparation)]. Of these factor groups, only
NR4A has a previously identiﬁed known motif.
We exclude from the discussion below motifs that we
consider unlikely to be relevant to our analysis, while
maintaining them as part of the overall resource where
they may be useful. These include 46 discovered motifs
that are either low-complexity (e.g. dinucleotide repeats)
or consistently have weak enrichment (<2) and do not
match known motifs (Supplementary Table S1). These
are likely a consequence of slight biases in the discovery
pipeline, or are due to real, but relatively weak, speciﬁcity
for the factor. We also exclude an additional 36 motifs
that have a weak similarity to the known motif for the
factor but for which a better matching and enriched motif
is also found (Supplementary Table S2). These are most
frequently seen for longer motifs that can be broken up
into recognizable, but globally dissimilar, patterns that are
not captured by our automatic exclusion criteria (see
Supplementary Methods). Together, these represent 28%
of the 293 discovered motifs.
RESULTS
Using motif similarity metrics, we are able to link the dis-
covered motifs directly to the TFs that recognize them
through their known motifs. Here we use these inferred
relationships between TFs to make speciﬁc biological
insights, illustrating the types of analyses that our
resource enables. In the interest of clarity, most descrip-
tions of TFs will be omitted, but may be found along with
further references at RefSeq (28) and Entrez (29).
Recovery of known speciﬁcity for TFs
Most of the known literature motifs we collect are derived
from biochemical in vitro assays. Thus, they provide a
largely independent, although somewhat imperfect way
to evaluate the performance of our discovered motifs.
Recovery of known motifs varies signiﬁcantly by
method, but taking the most enriched motif (our
pipeline) is competitive with the best single method
(Figure 3b). Overall, our pipeline found a motif
matching a previously characterized literature motif for
41 of the 56 factor groups with a known motif.
One of the most striking observations of this analysis is
how frequently other distinct motifs were also found. For
29 of these 41 factor groups other motifs are found, even
after manually excluding redundant or repetitive motifs,
and for 9 factor groups one or more of these discovered
motifs is ranked higher than the motif matching a known
motif (see Supplementary Table S3). In the next section,
we will analyze the additional motifs we found for these
factors, which in many cases identify factors known to
interact, either cooperatively or competitively.
For the remaining 15 of 56 factor groups with a known
motif (e.g. HSF, NANOG, PBX3, SREBP and TAL1) the
known motif is not found at all, including NR4A where
no enriched motif is discovered. Frequently this is because
the known motif itself is not enriched and may not accur-
ately capture the speciﬁcity of the factor in vivo. For
example, the ‘known’ EP300 motif from Transfac was
likely built on a speciﬁc bound region of EP300 and
would not accurately capture its binding in all cell types
where it interacts with a variety of factors and has no
DNA binding domain of its own (we avoided removing
such motifs to prevent bias in the database). Likewise, we
do not discover a motif that matches the known ZBTB33
speciﬁcity, and moreover the known motif itself is not
enriched at all in the bound regions.
Although some known motifs were of apparently low
quality, we largely found our database of known motifs to
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be relatively comprehensive and had difﬁculty ﬁnding
matches to novel motifs outside it. An exception is
ZNF263_disc1, which does not match a motif in our
database, but does roughly match the speciﬁcity for
ZNF263 indicated in (30) despite only having weak en-
richment (1.8-fold).
Although the motifs that match each other (either
known or discovered) generally have similar enrichments,
in some cases we ﬁnd substantially higher enrichment for
some motif variants over others (Figure 4 and
Supplementary Table S3). For example, NFE2_disc1
matches the known NFE2 motif, but has a 76-fold
maximal enrichment across NFE2 data sets, compared
with 56-fold enrichment for the most enriched known
NFE2 motif. Different known motifs for the same factor
often show a broad range in enrichment: MEF2 has six
motifs described in Transfac, with an enrichment differen-
tial of as much as 4-fold consistently across data sets. This
enrichment analysis provides a systematic way to choose
among variants of a motif.
We also saw varying enrichment of the known motif,
depending on the speciﬁc data set for a factor group. For
example, CTCF_known2 is enriched in CTCF data sets in
a range from 30- to 78-fold on identically processed data.
This may be a result of varying quality of the samples
across data sets or may be a consequence of true biological
differences.
Identifying the sequence speciﬁcity for factors that were
previously uncharacterized is of particular interest. In all,
17 factor groups had no known motif but now have dis-
covered enriched motifs (BCL, BDP1, CCNT2, CHD2,
CTCFL, HDAC2, HMGN3, RAD21, SETDB1, SIRT6,
SMARC, SMC3, SP2, SIN3A, THAP1, TRIM28 and
ZNF263). These discovered motifs may represent the
direct or indirect (e.g. through cofactors) DNA binding
speciﬁcity.
Shared motifs suggest interacting relationships
We ﬁnd that most factors have motifs for other factors
enriched in their binding sites (summarized in
Supplementary Table S4). This may occur due to (i) co-
operative binding of the two factors to the same locations;
(ii) interfering binding between factors where one binds
near the other to prevent binding; (iii) some similarity in
motif speciﬁcity; (iv) the two factors functioning on a
similar set of genes (e.g. ones speciﬁc to one tissue),
without directly interacting; or (v) the factors binding to
similar genomic regions (e.g. near genes). Our analysis
does not directly rule out any of these possibilities;
however, (iii) is generally veriﬁable using our motif simi-
larity metrics and (v) can be examined by inspecting only
the TSS-proximal enrichment.
The motif most enriched in multiple data sets was the
TPA DNA response element (TRE; TGA[C/G]TCA),
which is recognized by the AP1 TF when it is formed by
FOS/JUN dimers (31) and other factors including MAF
and NFE2. The enrichment of the TRE in a data set is
often stronger than that of even the known in vitro
sequence speciﬁcity and may arise from a number of phe-
nomena, including (i) a cooperatively interaction with
AP1, (ii) competition with AP1 for the same binding
sites, leading to a potentially repressive role for the TF
or (iii) reuse of binding sites due to, for example, accessi-
bility of chromatin. We ﬁnd a motif matching the TRE
motif for 20 factor groups (AP1_disc3, AP2_disc1,
BATF_disc1, BCL_disc2, CTCF_disc8-9, EP300_disc1,
GATA_disc2, HMGN3_disc1, IRF_disc2, MAF_disc1,
MEF2_disc3, MYC_disc3, NFE2_disc1, NR3C1_disc2,
PRDM1_disc2, RXRA_disc3, SMARC_disc1, STAT_
disc2, TCF7L2_disc1 and TRIM28_disc1).
We found that the enrichment of the TRE to be par-
ticularly notable for a few factors. GATA and AP1 have
Figure 2. Outline of motif discovery pipeline. Input regions for each data set are randomly partitioned into two groups. The top 250 regions of one
of the partitions are scanned for motifs using ﬁve de novo motif discovery tools. These motifs are evaluated using the peaks from the other
partitioned and pooled across data sets for a factor group to produce the ﬁnal list of discovered motifs for each factor group.
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known cooperative binding (32). TFs in the SMARC
factor group are members of the SWI/SNF chromatin
remodeling complex (33), which is necessary for proper
regulation by FOS/JUN dimers (34); and TCF7L2_
disc1, which matches the TRE, is more enriched than
the known TCF7L2 motif (TCF7L2_disc2) in only the
TCF7L2 colorectal cancer cell line HCF-116 data set, con-
sistent with the known interaction of JUN and TCF7L2
during intestinal cancer development (35).
AP1 also binds to the cAMP response element (CRE; T
GACGTCA) when the dimer is formed by ATF3/JUN
(31) and this is the motif we ﬁnd as AP1_disc1.
However, AP1_disc3 (which matches the TRE) is the
most enriched motif in FOS data sets. Interestingly,
ATF3_disc1 is not the CRE, but rather the E-box (see
later in text). We do, however, ﬁnd a variant of the
CRE (with additional speciﬁcity) as ATF3_disc2. The
most enriched discovered motif for E2F, E2F_disc1 also
matches the CRE and is highly enriched in all data sets.
MYC is a critical regulator, which recognizes the E-box
sequence. To aid in comparisons, we include MAX, which
forms complexes with MYC, and USF1/2, which also rec-
ognizes the E-box sequence, in the MYC factor group.
(a)
(b)
Figure 3. (a) Summary of input data used. The outside ring indicates
the experimental data sets (one tick for each of 427), which are
separated into 123 transcription factors (second ring). The TFs are
further grouped into 84 factor groups (third ring). We are able to
ﬁnd a matching discovered motif for 41 of the 56 factor groups with
a known motif; 29 of these 41 factor groups have additional discovered
motifs that may be associated with cofactors. For all but 1 of the 15
factor groups where the known motif is not recovered we still ﬁnd
enriched discovered motifs. We also discovered enriched motifs for 17
of the 28 factor groups without a known motif. (b) Recovery of known
motifs by each of the discovery tools. Performance of discovery in
terms of number of factor groups for which the known motif was re-
covered. A motif is considered a match if it matches any of the known
motifs for a factor group (see Supplementary Methods for details on
how matches are computed). The number of additional factors that
have a match is shown with each additional motif (only three motifs
are taken from each individual method, whereas we have up to 10 for
the pipeline). The number of factor groups with no motif match is
shown in parenthesis. When multiple data sets exist for a factor
group, the fraction that matches is used in computing its contribution
for computing the performance of the individual tools.
Figure 4. Comparison of known versus discovered motifs (selected
where discovered better enriched than known; all factor groups with
a discovered motif matching a known motif in Supplementary Table
S3). Displayed is the known and discovered motif with the maximum
enrichment across all data sets for a factor group. Only the discovered
motifs that match a known motif for a factor group are considered.
The maximum enrichment is indicated for each factor and, in paren-
thesis, the ‘raw’ enrichment for the same data set without the use of the
shufﬂe motifs for correction.
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We ﬁnd multiple motifs enriched in MYC binding sites,
highlighting the multifunctional role MYC and the other
E-box recognizing proteins play. We found a version of
the E-box with additional speciﬁcity (MYC_disc1) that
was highly enriched in USF1/2 bound regions (max 98-
fold for USF2 versus <9-fold enrichment for MYC/
MAX). This motif was more enriched than the known
E-box motifs, including known USF motifs, in many
USF data sets. We ﬁnd a second, less speciﬁc E-box
motif (MYC_disc2), which shows more even enrichment
across factors. We also ﬁnd discovered motifs of other
factors matching the E-box, including SIN3A_disc2 (dis-
cussed later in text), NFE2_disc2-3 and SIRT6_disc1. It is
notable that although SIRT6 is a chromatin-associated
protein without a known DNA binding domain (36), the
only discovered motif matches the E-box (with 16-fold
enrichment in SIRT6 bound regions), suggesting that
MYC or another E-box recognizing factor may play an
important, but indirect, chromatin-related role.
Motif enrichment is able to identify both positive and
negative interactions for the same factor. For example,
SIN3A, a corepressor known to interact with a number
of proteins, has discovered motifs matching REST
(SIN3A_disc1 and more weakly disc3–4) and MYC
(SIN3A_disc2). These are consistent with SIN3A’s
known involvement in repression by REST (37) and
SIN3A being a known antagonist for MYC (38).
Morever, MYC_disc4 matches RFX5 and is enriched
particularly for MAX-bound regions in H1-hESC and
GM12878, and MYC_disc5 matches the CEBPB known
motif and is enriched in MYC regions bound in unstimu-
lated K562 cells. MXI1, which was not included in the
MYC factor group although it does interact with MAX
to bind to MYC-MAX sites (39), has MXI1_disc1 that
matches RFX5 in both the K562 and HeLa-S3 cell lines.
We analyzed six IRF family data sets: IRF1 binding in
K562 cells stimulated by IFNa (viral innate response) or
IFNg (viral, bacterial and tumor control); IRF3 in
HepG2, GM12878 and HeLa-S3; and IRF4 in
GM12878. The most strongly enriched motif
(IRF_disc1, matching NFY) is highly enriched (>20-
fold) for all three IRF3 data sets and IRF1 in K562
under IFNg stimulation. This suggests that binding of
IRF to NFY sites occurs only under speciﬁc conditions
and by only some IRF members and potentially expands
on the previously documented interaction of NFY and
IRF2 at a single promoter (40). IRF_disc4, which
matches SP1, is enriched in the same cell types, albeit at
much lower levels. IRF_disc3, which matches the known
IRF consensus, shows weak-to-no enrichment in these
data sets, but shows an enrichment of 8.8-fold for IRF1
bound regions in K562 cells under IFNa stimulation and
3.1-fold enrichment for IRF4 bound regions in GM12878.
IRF_disc2, which matches the TRE, is enriched primarily
in GM12878 regions bound by IRF4. The known SPI1
motif matches IRF_disc5, and reciprocally SPI1_disc2
matches the IRF motif, consistent with the importance
of SPI1 in hematopoietic development (41).
Beyond the discovered motif for IRF, several other dis-
covered motifs (AP1_disc2, CEBP_disc2, E2F_disc4,
PBX3_disc1, RFX5_disc2 and SP1_disc1-2) match the
known NFY speciﬁcity (CCAAT). These discovered
motifs are consistent with several known interactions of
NFY. RFX5 promotes the cooperative binding between
RFX and NFY (42), CEBPB and NFY interact in at least
one promoter (43) and SP1 and NFY are known to
interact (44). E2F_disc4 has particularly high enrichment
in E2F4 data sets, consistent with the cooperative role
E2F4 and NFY play in cell cycle regulation (45).
STAT factors are involved in regulating number of
growth-related functions. We analyze STAT1, STAT2
and STAT3 here in the context of GM12878, HeLa-S3,
MCF10A-Er-Src and K562 cells. We ﬁnd relatively con-
sistent enrichment of the STAT full site (TTCCNGGAA),
which STAT_disc1 matches, while ﬁnding weak enrich-
ment for just the half-site (TTCC). We also ﬁnd motifs
involved in other proliferative functions including
STAT_disc2, which is particularly enriched in STAT3
data sets and matches the TRE, consistent with STAT3
being one of the many interaction partners for AP1 (46).
STAT_disc3 matches the IRF consensus and has enrich-
ment that is particularly high in STAT1 and STAT2 data
sets stimulated by IFNa, highlighting the cooperativity of
STAT factors and IRF in immune functions. STAT_disc4
is a match to the CEBPB motif and is found enriched in
STAT3 data sets, consistent with the known cooperative
role for these two factors (47).
TFs with ETS domains are highly conserved and
involved in several cellular processes [reviewed in (48)].
A number of TFs have discovered motifs that match the
ETS consensus, including EGR1_disc2, GATA_disc3,
MEF2_disc2, NRF1_disc2, NR2C2_disc1 and
PAX5_disc4. These discovered motifs are supported by
known interactions between GATA and ETS in sea
squirts (49), MEF2 and the ETS factor PEA3 (50) and
NR2C2 with the ETS factor ELK4 (51). Moreover,
PAX5 and ETS factors have shared roles in the develop-
ment of B-cells (52,53). Looking at the discovered ETS
motifs, we ﬁnd that ETS_disc8 matches the known motif
for MYB and the two have been known to cooperate, a
relationship that is important in the context of certain
cancers (54).
THAP1 has two discovered motifs, both of which
match the known YY1 motif (the ﬁrst with additional
speciﬁcity added by an apparent HNF4 motif). To our
knowledge, the relationship between THAP1 and YY1
has not been directly observed; however, THAP1 has
been known to associate with the coactivator HCF-1
(55), and YY1 and HCF-1 are known to interact (56).
Our result suggests that THAP1 and YY1, possibly with
the addition of HNF4, may interact at least in the K562
cell line for which we have THAP1 binding data.
RAD21_disc3 also matches YY1, suggesting an additional
interaction.
NANOG, an important pluripotency TF, has a known
motif that is only weakly enriched (1.3-fold) in the bound
regions and not discovered by our pipeline. We see much
stronger enrichment for the known POU5F1 and
POU2F2 motifs, for which we also ﬁnd similar motifs
(NANOG_disc2 and NANOG_disc4, respectively), con-
sistent with their shared roles in pluripotency (57,58).
The interaction of these factors is further supported by
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POU5F1_disc2 matching the known POU2F2 motif.
Additionally, NANOG_disc2 and disc3 match the
known motifs for TCF7L2 and TCF12, respectively,
again consistent with the important role TCF proteins
play in stem cells (59).
CTCF plays a variety of vital roles in the organization
of chromatin architecture (60) and the motifs we discover
matching the known CTCF speciﬁcity (RAD21_disc1,
SMC3_disc1,2-4, CTCFL_disc1,10, ZBTB7A_disc1,2,
SP2_disc3 and RXRA_disc2,5; some weakly) are largely
compatible with this role. RAD21 is a highly conserved
protein involved in DNA double-strand repair (61) known
to co-localize with CTCF (62). Cohesin, of which SMC3 is
a subunit, is brought to the chromatin by CTCF (63).
Further, although the function of the CTCF paralog
CTCFL is not completely known, it does appear to be
involved in imprinting through interaction with a
histone methyltransferase (64).
Combinations of motifs
A few of the discovered motifs contain additional speciﬁ-
city or have distinct segments matching multiple motifs.
For example, EGR1_disc4 appears to be a combination of
multiple motifs (EGR1, IKZF1 and a homeobox motif),
and SETDB1_disc1 contains the ZNF143 core sequence
with signiﬁcant additional speciﬁcity. The appearance of
these motifs suggests highly speciﬁc ‘grammars’ for these
motifs that may require speciﬁc spacing and orientation of
binding sites for functionality.
We ﬁnd several additional enrichments of potential
interest. PBX3_disc2 matches the known MEIS1 motif,
consistent with the known cooperative binding of
MEIS1 and PBX (65). TAL1_disc1 matches GATA,
with the potential connection that GATA and TAL1 are
known to be important in hematopoesis and vascular de-
velopment (66,67). HSF_disc1 matches the known CEBP
motif and has much higher enrichment in HSF data sets
(31-fold) compared with the known motifs for HSF (<9-
fold). Additionally, EGR1_disc5, HNF4_disc5,
NRF1_disc3, PAX5_disc2, RXRA_disc4/PAX5_disc3
and SREBP_disc1 match the known motifs for ZIC,
SOX, SP1, PAX2/PAX3, IRF and RFX5, respectively,
suggesting additional previously uncharacterized inter-
actions. Lastly, we ﬁnd some motifs that show more am-
biguous matches: SMARC_disc2 shows weak similarity to
homeobox TGTAGT motif, NR2C2_disc2–3 weakly
matches the known HNF4 motif and EGR1_disc3/
SETDB1_disc2 matches the repetitive NRF1 motif.
General factors enriched in cell line-speciﬁc key regulators
Factors directly responsible for the establishment of en-
hancers, chromatin restructuring or polymerase recruit-
ment frequently exhibit binding that is highly cell type
speciﬁc. Because most of these factors do not have their
own sequence speciﬁcity, their binding is often correlated
with that of regulators important for the speciﬁc cell line.
We analyze several such factors (BCL, BDP1, CCNT2,
EP300, FOXA, HDAC2, HMGN3, TATA, TCF12 and
TRIM28) and ﬁnd that key cell line regulators can be
identiﬁed by examining enrichments in cell lines-speciﬁc
data sets.
As a transcriptional coactivator, EP300 interacts with
numerous TFs [reviewed in (68)] and has been shown to
have binding that can identify tissue-speciﬁc enhancers
(69). Conversely, FOXA has a DNA binding domain
and plays an important role in liver development and
function (70) and is a pioneer factor responsible for
priming chromatin for the binding of other factors
(reviewed in (71)]. Other proteins involved in chromatin
restructuring include HDAC2, which transcriptionally
represses through histone deacetylation (72) and
HMGN3 (73). Further, two factor groups are directly
involved in transcription including three RNA Pol3
subunits (BDP1, RPC155 and TFIIIC-110) and CCNT2,
which is involved in the elongation of Pol2 (74).
Eight of these ten factor groups have at least one data
set in K562 (erythroleukemia cells), and for four of these
we discover motifs that match the GATA consensus,
which is then enriched speciﬁcally in the K562 data sets
(BCL_disc5, CCNT2_disc1, HDAC2_disc1 and
HMGN3_disc2). GATA has a known important role in
K562 (75), and we also have previously found an associ-
ation with GATA motifs and chromatin state-derived en-
hancers for K562 cells (76). We also ﬁnd three additional
motifs that have enrichment speciﬁc to the factor group’s
K562 data set: BDP1_disc1, a 23-nt motif that contains
the STAT consensus; HMGN3_disc1, which matches the
TRE; and TRIM28_disc2, which matches no known motif
and may be associated with an uncharacterized regulator
active in this cell line.
Likewise, for GM12878, an EBV-mediated
lymphoblastoid cell line, we ﬁnd three discovered motifs
(BCL_disc4, EP300_disc5 and TCF12_disc4) that match
the known IRF consensus. IRF4 has been shown to be
important in the establishment of these cell lines (77), and
the family is an important player in immune cells (78).
This enrichment is also consistent with our previous
study using epigenetic marks (76), where we found IRF
to be the strongest enriched motif in GM12878-speciﬁc
enhancers. We also ﬁnd GM12878-speciﬁc enrichment
for motifs matching NFKB (BCL_disc6) and POU2F2
(TATA_disc9), consistent with the known biology of
these factors (79,80).
The motifs we ﬁnd speciﬁcally enriched in HepG2 (liver
carcinoma) data sets match the known motifs for FOXA
(EP300_disc3, HDAC2_disc2, and TCF12_disc2), HNF4
(FOXA_disc5 and HDAC2_disc5) and CEBP
(EP300_disc2,6), three key liver regulators (70,81). We
ﬁnd motifs with enrichments speciﬁc to H1-hESC, which
include matches to the pluripotency factor POU2F2
(TATA_disc9), the near universally expressed repressor
REST (BCL_disc3 and HDAC2_disc4) and key metabolic
regulator NRF1 (HDAC2_disc4). We ﬁnd additional cell
line-speciﬁc enrichments for FOXA_disc3 (TCF12) in
ECC-1, FOXA_disc4 (STAT) in both T-47D and ECC-1
and EP300_disc2,6 (CEBP) and EP300_disc4 (ETS) with
enrichment in the HeLa-S3 data set.
Even for these factors, we ﬁnd motifs that are consist-
ently enriched across assayed cell lines for a given factor.
FOXA_disc1, for example, matches the known FOXA
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motif, indicating that FOXA’s own motif also plays an
important role in its speciﬁcity. Most of the motifs we
identify for RNA Pol2 machinery (TAF1, GTF2B,
GTF2F1 and TBP) are enriched in all cell lines, including
the known TATAAA motif (TATA_known2). Also,
TATA_disc1, disc6 and disc8 have consistent enrichment
and match the known motifs for YY1 (which is known to
be important in establishing transcription) (82), NFY and
ETS. The top discovered motif BCL_disc1 matches the
known ETS motif and is also enriched across data sets.
Interestingly, we ﬁnd that the TRE motif is found and
enriched in a cell line-speciﬁc manner for several factors,
but for different cell lines. For example, HMGN3_disc1 is
enriched in K562, BCL_disc2 has the highest enrichment
in GM12878, TRIM28_disc1 is only enriched in the
HEK2932 and U2OS cell lines and EP300_disc7 has en-
richment in the neuroblastoma cell line SK-N-SH-RA and
HeLa-S3. This suggests that perhaps AP1 or other factors
recognizing TRE are selectively interacting with these
proteins depending on the cell line.
Novel motifs raise possibility of unknown regulators
Although we are able to putatively explain the majority
of the motifs we discover as either matches to previously
known motifs or low complexity sequences, we do identify
30 putative novel motifs (Figure 5). We placed
these into eight groups on the basis of their similarity:
Novel1 (BRCA1_disc1, CHD2_disc1, ETS_disc3,6,
NR3C1_disc3 and ZBTB33_disc1-4), Novel2 (EGR1_
disc4, ETS_disc1,5,7, SETDB1_disc1, SIX5_disc1-3,
SMARC_disc2 and ZNF143_disc1-3), Novel3
(SP2_disc3, TCF12_disc3 and ZBTB7A_disc2), Novel4
(RFX5_disc3), Novel5 (BDP1_disc2), Novel6
(TATA_disc5,7), Novel7 (TRIM28_disc2) and Novel8
(E2F_disc6).
Novel1 (using ZBTB33_disc1) is highly enriched in at
least one data set for each of the factor groups for which
it is found (BRCA1, CHD2, ETS, NR3C1 and ZBTB33).
All ﬁve factor groups except CHD2 have at least one
known motif, and for each of these data sets Novel1 is
more enriched in at least one data set than any known
motif [the result for NR3C1 is questionable because only
one data set has enrichment and that data set has been
independently ﬂagged as problematic; see http://www.
encodeproject.org/encode/qualityMetrics.html]. The
shared role of BRCA1 and CHD2 in DNA damage
repair (83,84) suggests that Novel1 may be involved in
this or other shared roles for these factors and highlights
the utility in sharedmotif enrichment even outside ofmotifs
directly tied to a factor.
Similarly, for SIX5, we see only weak enrichment of the
known SIX5 motif and fail to discover a motif similar to
it. However, Novel2 (using SIX5_disc1) shows over 100-
fold enrichment for all three data sets (K562, GM12878
and H1-hESC). Novel2 also shows high enrichment in
data sets for which it was not rediscovered, including
ATF3 (all data sets have >20-fold enrichment with
GM12878 having 106-fold) and NRF1 (all data sets
have >30-fold enrichment). Moreover, the known
ZNF143 motif, which is 4-fold enriched in the one
ZNF143 data set, is also not recovered, but Novel2 is
24-fold enriched. The breath of data sets sharing this
motif suggests it may be recognized by an important yet
unknown or under-characterized regulator.
Like the known ZBTB7A motif, Novel3 (using
SP2_disc3) is largely poly-G, which causes us to underesti-
mate its enrichment due to our shufﬂing process. Despite
Figure 5. Putative novel motifs. We ﬁnd eight motifs that are not represented in the literature motifs we collected, three of which are found for at
least two factor groups. These patterns may represent the binding speciﬁcity of the factors for which they are discovered or for other factors that
cooperate with them.
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this, however, it does show enrichment in several data sets,
including for the factor groups for which it was identiﬁed.
This motif shows similarity to other poly-G motifs, such
as known SP1 motifs, but appears to be distinct due to its
other bases.
Novel4 (RFX5_disc3) shows moderate, but consistent
(2- to 6-fold) enrichment across the RFX5 data sets. The
consensus is composed of two of the same components as
the known motifs (AAC and TGA), but ordered differ-
ently. Consequently, it may represent the binding speciﬁ-
city of, for example, an alternative isoform of RFX5. The
remaining motifs (Novel5-8), were found for factors that
show cell line-speciﬁc enrichments. Consequently, these
may represent speciﬁcities for regulators that are previ-
ously unidentiﬁed.
Experimental and evolutionary validation of novel motifs
Following the motif discovery and selection of these
putative novel motifs, a study released hundreds of new
motifs generated using high-throughput SELEX (16). Two
of the putative novel motifs described in this section match
motifs generated by (16): Novel1 matches the motif
for ETV6 and Novel6 matches ZBED1. Although we
have incorporated these SELEX motifs into our
resource, we continue to include Novel1 and Novel6 as
putative novel motifs because they were identiﬁed
without knowledge of these new speciﬁcities and thereby
strengthen the evidence for the remaining novel motifs.
Four of these putatively novel motif groups (Novel1–3,
6) match motifs that were previously identiﬁed using
conservation signals across four mammals (85)
(Supplementary Table S5). Therefore, this study
provides additional support for these conservation-based
motifs and, conversely, the motifs identiﬁed here gain
comparative evidence. The relatively few distinct novel
patterns that are found in this study and the comparative
support for many of the few that are found suggests that
there may be a limited number of human TF motifs with
many instances and which interact with one of the assayed
factors that remain unknown.
DISCUSSION
In this article, we provide a systematic and comprehensive
collection of motifs for hundreds of human TF binding
data sets. TF binding can be complex, with a factor
recognizing several or motifs or binding in the apparent
absence of any motif [reviewed in (86)]. We also show that
it is possible to identify cofactors that may be partially
responsible for binding or function.
This motif resource has already been used in several
articles while this article was in preparation, demon-
strating its value for high-throughput analyses. Our
motifs are being matched at low stringency to identify
peaks that are void of any motif to understand the mech-
anism through which motif-less peaks are generated (8).
The collection of known motifs and enrichment tech-
niques we present here was also used as a secondary
validation of peaks (87). Because having the motifs
allows for more precisely determining the bases
responsible for binding, these motifs enable analyzes
involving population data (88) and for interpreting
GWAS data (89). Two other ENCODE articles also
perform motif discovery: (90) produce a non-redundant
list of discovered motifs but do not perform an extensive
analysis of the relationships between factors and (91) use
DNaseI footprinting data to identify relevant motifs.
Having a motif catalog is also the ﬁrst step in identify-
ing high-quality computational targets of factors, which
may allow the identiﬁcation of binding sites that were, for
example, not found in the conditions assayed. Two
popular strategies are used for this purpose. One is using
clustering of motif instances for factors known to cooper-
ate to form cis-regulatory modules (92,93). This resource
is well suited for this purpose because it naturally provides
sets of motifs that are likely to cooperate.
A second approach is the use of conservation on many
closely related species (85,94–97). This can be performed
readily on these motif instances because a dense tree of
mammalian species has been sequenced readily permitting
their alignment and measuring selection of a near-nucleo-
tide level. Because changes in the underlying motif
matches are largely responsible for changes in binding
across species (98), evolutionary-based approaches on
the motif instances may be a means to deal with the
high rate of non-functional binding (99–101).
AVAILABILITY
A web interface, along with data ﬁles and accompanying
software, is available at http://compbio.mit.edu/encode-
motifs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [102–110].
ACKNOWLEDGEMENTS
The authors thank Ewan Birney, Christopher Bristow,
Luke Ward, Jason Ernst, Anshul Kundaje, Gerald Quon
and other members of the Kellis Laboratory for helpful
discussions.
FUNDING
National Institutes of Health (NIH) [HG004037,
HG007000 and HG006991]. Funding for open access
charge: NIH [HG004037, HG007000 and HG006991].
Conﬂict of interest statement. None declared.
REFERENCES
1. Solomon,M.J., Larsen,P.L. and Varshavsky,A. (1988) Mapping
proteinDNA interactions in vivo with formaldehyde: evidence that
histone H4 is retained on a highly transcribed gene. Cell, 53,
937–947.
2. Ren,B., Robert,F., Wyrick,J.J., Aparicio,O., Jennings,E.G.,
Simon,I., Zeitlinger,J., Schreiber,J., Hannett,N., Kanin,E. et al.
Nucleic Acids Research, 2013 9
 at M
IT Libraries on February 12, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
(2000) Genome-wide location and function of DNA binding
proteins. Science, 290, 2306–2309.
3. Iyer,V.R., Horak,C.E., Scafe,C.S., Botstein,D., Snyder,M. and
Brown,P.O. (2001) Genomic binding sites of the yeast cell-cycle
transcription factors SBF and MBF. Nature, 409, 533–538.
4. Robertson,G., Hirst,M., Bainbridge,M., Bilenky,M., Zhao,Y.,
Zeng,T., Euskirchen,G., Bernier,B., Varhol,R., Delaney,A. et al.
(2007) Genome-wide proﬁles of STAT1 DNA association using
chromatin immunoprecipitation and massively parallel sequencing.
Nat. Methods, 4, 651–657.
5. Qi,Y., Rolfe,A., MacIsaac,K.D., Gerber,G.K., Pokholok,D.,
Zeitlinger,J., Danford,T., Dowell,R.D., Fraenkel,E., Jaakkola,T.S.
et al. (2006) High-resolution computational models of genome
binding events. Nat. Biotechnol., 24, 963–970.
6. Guo,Y., Papachristoudis,G., Altshuler,R.C., Gerber,G.K.,
Jaakkola,T.S., Gifford,D.K. and Mahony,S. (2010) Discovering
homotypic binding events at high spatial resolution.
Bioinformatics, 26, 3028–3034.
7. Li,X.Y., MacArthur,S., Bourgon,R., Nix,D., Pollard,D.A.,
Iyer,V.N., Hechmer,A., Simirenko,L., Stapleton,M., Hendriks,C.L.
et al. (2008) Transcription factors bind thousands of active and
inactive regions in the Drosophila blastoderm. PLoS Biol., 6, e27.
8. The ENCODE Project Consortium. (2012) An integrated
encyclopedia of DNA elements in the human genome. Nature,
489, 57–74.
9. Moorman,C., Sun,L.V., Wang,J., deWit,E., Talhout,W.,
Ward,L.D., Greil,F., Lu,X., White,K.P., Bussemaker,H.J. et al.
(2006) Hotspots of transcription factor colocalization in the
genome of Drosophila melanogaster. Proc. Natl Acad. Sci. USA,
103, 12027–12032.
10. Gerstein,M.B., Kundaje,A., Hariharan,M., Landt,S.G., Yan,K.-
K., Cheng,C., Mu,X.J., Khurana,E., Rozowsky,J., Alexander,R.
et al. (2012) Architecture of the human regulatory network
derived from ENCODE data. Nature, 489, 91–100.
11. Matys,V., Fricke,E., Geffers,R., Gossling,E., Haubrock,M.,
Hehl,R., Hornischer,K., Karas,D., Kel,A.E., Kel-Margoulis,O.V.
et al. (2003) TRANSFAC(R): transcriptional regulation, from
patterns to proﬁles. Nucleic Acids Res., 31, 374–378.
12. Sandelin,A., Alkema,W., Engstrm,P., Wasserman,W.W. and
Lenhard,B. (2004) JASPAR: an open-access database for
eukaryotic transcription factor binding proﬁles. Nucleic Acids
Res., 32, D91–D94.
13. Berger,M.F., Philippakis,A.A., Qureshi,A.M., He,F.S., Estep,P.W.
and Bulyk,M.L. (2006) Compact, universal DNA microarrays to
comprehensively determine transcription-factor binding site
speciﬁcities. Nat. Biotechnol., 24, 1429–1435.
14. Badis,G., Berger,M.F., Philippakis,A.A., Talukder,S.,
Gehrke,A.R., Jaeger,S.A., Chan,E.T., Metzler,G., Vedenko,A.,
Chen,X. et al. (2009) Diversity and complexity in DNA
recognition by transcription factors. Science, 324, 1720–1723.
15. Berger,M.F., Badis,G., Gehrke,A.R., Talukder,S.,
Philippakis,A.A., Pea-Castillo,L., Alleyne,T.M., Mnaimneh,S.,
Botvinnik,O.B., Chan,E.T. et al. (2008) Variation in
homeodomain DNA binding revealed by high-resolution analysis
of sequence preferences. Cell, 133, 1266–1276.
16. Jolma,A., Yan,J., Whitington,T., Toivonen,J., Nitta,K.R.,
Rastas,P., Morgunova,E., Enge,M., Taipale,M., Wei,G. et al.
(2013) DNA-binding speciﬁcities of human transcription factors.
Cell, 152, 327–339.
17. Hughes,J.D., Estep,P.W., Tavazoie,S. and Church,G.M. (2000)
Computational identiﬁcation of Cis-regulatory elements associated
with groups of functionally related genes in Saccharomyces
cerevisiae. J. Mol. Biol., 296, 1205–1214.
18. Liu,X.S., Brutlag,D.L. and Liu,J.S. (2002) An algorithm for
ﬁnding protein-DNA binding sites with applications to chromatin-
immunoprecipitation microarray experiments. Nat. Biotechnol., 20,
835–839.
19. Bailey,T.L. and Elkan,C. (1994) Fitting a mixture model by
expectation maximization to discover motifs in biopolymers.
Proc. Int. Conf. Int. Syst. Mol. Biol., 2, 28–36.
20. Pavesi,G., Mauri,G. and Pesole,G. (2001) An algorithm for
ﬁnding signals of unknown length in DNA sequences.
Bioinformatics, 17, S207–S214.
21. Ettwiller,L., Paten,B., Ramialison,M., Birney,E. and Wittbrodt,J.
(2007) Trawler: de novo regulatory motif discovery pipeline for
chromatin immunoprecipitation. Nat. Methods, 4, 563–565.
22. Che,D., Jensen,S., Cai,L. and Liu,J.S. (2005) BEST: binding-site
estimation suite of tools. Bioinformatics, 21, 2909–2911.
23. Romer,K.A., Kayombya,G. and Fraenkel,E. (2007) WebMOTIFS:
automated discovery, ﬁltering and scoring of DNA sequence
motifs using multiple programs and Bayesian approaches. Nucleic
Acids Res., 35, W217–W220.
24. Sun,H., Yuan,Y., Wu,Y., Liu,H., Liu,J.S. and Xie,H. (2010)
Tmod: toolbox of motif discovery. Bioinformatics, 26, 405–407.
25. Crooks,G.E., Hon,G., Chandonia,J. and Brenner,S.E. (2004)
WebLogo: a sequence logo generator. Genome Res., 14,
1188–1190.
26. Bar-Joseph,Z., Gifford,D.K. and Jaakkola,T.S. (2001) Fast
optimal leaf ordering for hierarchical clustering. Bioinformatics,
17, S22–S29.
27. Bairoch,A. (2004) The Universal Protein Resource (UniProt).
Nucleic Acids Res., 33, D154–D159.
28. Pruitt,K.D. and Maglott,D.R. (2001) RefSeq and LocusLink:
NCBI gene-centered resources. Nucleic Acids Res., 29, 137–140.
29. Maglott,D., Ostell,J., Pruitt,K.D. and Tatusova,T. (2007) Entrez
gene: gene-centered information at NCBI. Nucleic Acids Res., 35,
D26–D31.
30. Frietze,S., Lan,X., Jin,V.X. and Farnham,P.J. (2010) Genomic
targets of the KRAB and SCAN domain-containing zinc ﬁnger
protein 263. J. Biol. Chem., 285, 1393–1403.
31. Karin,M., Liu,Z.g. and Zandi,E. (1997) AP-1 function and
regulation. Curr. Opin. Cell Biol., 9, 240–246.
32. Kawana,M., Lee,M.E., Quertermous,E.E. and Quertermous,T.
(1995) Cooperative interaction of GATA-2 and AP1 regulates
transcription of the endothelin-1 gene. Mol. Cell. Biol., 15,
4225–4231.
33. Wang,W., Xue,Y., Zhou,S., Kuo,A., Cairns,B.R. and
Crabtree,G.R. (1996) Diversity and specialization of mammalian
SWI/SNF complexes. Genes Dev., 10, 2117–2130.
34. Ito,T., Yamauchi,M., Nishina,M., Yamamichi,N., Mizutani,T.,
Ui,M., Murakami,M. and Iba,H. (2001) Identiﬁcation of
SWI.SNF complex subunit BAF60a as a determinant of the
transactivation potential of Fos/Jun dimers. J. Biol. Chem., 276,
2852–2857.
35. Nateri,A.S., Spencer-Dene,B. and Behrens,A. (2005) Interaction of
phosphorylated c-Jun with TCF4 regulates intestinal cancer
development. Nature, 437, 281–285.
36. Mostoslavsky,R., Chua,K.F., Lombard,D.B., Pang,W.W.,
Fischer,M.R., Gellon,L., Liu,P., Mostoslavsky,G., Franco,S.,
Murphy,M.M. et al. (2006) Genomic instability and aging-like
phenotype in the absence of mammalian SIRT6. Cell, 124,
315–329.
37. Huang,Y., Myers,S.J. and Dingledine,R. (1999) Transcriptional
repression by REST: recruitment of Sin3A and histone
deacetylase to neuronal genes. Nat. Neurosci., 2, 867–872.
38. Nascimento,E.M., Cox,C.L., Macarthur,S., Hussain,S.,
Trotter,M., Blanco,S., Suraj,M., Nichols,J., Kbler,B., Benitah,S.A.
et al. (2011) The opposing transcriptional functions of Sin3a and
c-Myc are required to maintain tissue homeostasis. Nat. Cell
Biol., 13, 1395–1405.
39. Zervos,A.S., Gyuris,J. and Brent,R. (1993) Mxi1, a protein that
speciﬁcally interacts with Max to bind Myc-Max recognition sites.
Cell, 72, 223–232.
40. Li-Weber,M., Davydov,I., Krafft,H. and Krammer,P. (1994) The
role of NF-Y and IRF-2 in the regulation of human IL-4 gene
expression. J. Immunol., 153, 4122–4133.
41. Scott,E., Simon,M., Anastasi,J. and Singh,H. (1994) Requirement
of transcription factor PU.1 in the development of multiple
hematopoietic lineages. Science, 265, 1573–1577.
42. Villard,J., Peretti,M., Masternak,K., Barras,E., Caretti,G.,
Mantovani,R. and Reith,W. (2000) A functionally essential
domain of RFX5 mediates activation of major histocompatibility
complex class II promoters by promoting cooperative binding
between RFX and NF-Y. Mol. Cell. Biol., 20, 3364–3376.
43. Yu,L., Wu,Q., Yang,C.P. and Horwitz,S.B. (1995) Coordination
of transcription factors, NF-Y and C/EBP beta, in the regulation
of the mdr1b promoter. Cell Growth Differ., 6, 1505–1512.
10 Nucleic Acids Research, 2013
 at M
IT Libraries on February 12, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
44. Roder,K., Wolf,S., Larkin,K. and Schweizer,M. (1999) Interaction
between the two ubiquitously expressed transcription factors
NF-Y and Sp1. Gene, 234, 61–69.
45. Caretti,G., Salsi,V., Vecchi,C., Imbriano,C. and Mantovani,R.
(2003) Dynamic recruitment of NF-Y and histone
acetyltransferases on cell-cycle promoters. J. Biol. Chem., 278,
30435–30440.
46. Ivanov,V.N., Bhoumik,A., Krasilnikov,M., Raz,R.,
Owen-Schaub,L.B., Levy,D., Horvath,C.M. and Ronai,Z. (2001)
Cooperation between STAT3 and c-jun suppresses fas
transcription. Mol. Cell, 7, 517–528.
47. Choi,S., Cho,Y., Kim,H. and Park,J. (2007) ROS mediate the
hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha
and STAT-3. Biochem. Biophys. Res. Commun., 356, 312–317.
48. Sementchenko,V.I. and Watson,D.K. (2000) Ets target genes:
past, present and future. Oncogene, 19, 6533–6548.
49. Rothbcher,U., Bertrand,V., Lamy,C. and Lemaire,P. (2007) A
combinatorial code of maternal GATA, Ets and beta-catenin-
TCF transcription factors speciﬁes and patterns the early ascidian
ectoderm. Development, 134, 4023–4032.
50. Taylor,J.M., Dupont-Versteegden,E.E., Davies,J.D., Hassell,J.A.,
Houl,J.D., Gurley,C.M. and Peterson,C.A. (1997) A role for the
ETS domain transcription factor PEA3 in myogenic
differentiation. Mol. Cell. Biol., 17, 5550–5558.
51. O’Geen,H., Lin,Y., Xu,X., Echipare,L., Komashko,V.M., He,D.,
Frietze,S., Tanabe,O., Shi,L., Sartor,M.A. et al. (2010) Genome-
wide binding of the orphan nuclear receptor TR4 suggests its
general role in fundamental biological processes. BMC Genomics,
11, 689.
52. Adams,B., Drﬂer,P., Aguzzi,A., Kozmik,Z., Urbnek,P.,
Maurer-Fogy,I. and Busslinger,M. (1992) Pax-5 encodes the
transcription factor BSAP and is expressed in B lymphocytes, the
developing CNS, and adult testis. Genes Dev., 6, 1589–1607.
53. Fitzsimmons,D., Hodsdon,W., Wheat,W., Maira,S.M., Wasylyk,B.
and Hagman,J. (1996) Pax-5 (BSAP) recruits Ets proto-oncogene
family proteins to form functional ternary complexes on a B-cell-
speciﬁc promoter. Genes Dev., 10, 2198–2211.
54. Dudek,H., Tantravahi,R.V., Rao,V.N., Reddy,E.S. and
Reddy,E.P. (1992) Myb and Ets proteins cooperate in
transcriptional activation of the mim-1 promoter. Proc. Natl
Acad. Sci. USA, 89, 1291–1295.
55. Mazars,R., Gonzalez-de-Peredo,A., Cayrol,C., Lavigne,A.,
Vogel,J.L., Ortega,N., Lacroix,C., Gautier,V., Huet,G., Ray,A.
et al. (2010) The THAP-zinc ﬁnger protein THAP1 associates
with coactivator HCF-1 and O-GlcNAc transferase: a link
between DYT6 and DYT3 dystonias. J. Biol. Chem., 285,
13364–13371.
56. Yu,H., Mashtalir,N., Daou,S., Hammond-Martel,I., Ross,J.,
Sui,G., Hart,G.W., Rauscher,F.J.R., Drobetsky,E., Milot,E. et al.
(2010) The ubiquitin carboxyl hydrolase BAP1 forms a ternary
complex with YY1 and HCF-1 and is a critical regulator of gene
expression. Mol. Cell. Biol., 30, 5071–5085.
57. Looijenga,L.H., Stoop,H., deLeeuw,H.P., deGouveia Brazao,C.A.,
Gillis,A.J., vanRoozendaal,K.E., vanZoelen,E.J., Weber,R.F.,
Wolffenbuttel,K.P., vanDekken,H. et al. (2003) POU5F1 (OCT3/
4) identiﬁes cells with pluripotent potential in human germ cell
tumors. Cancer Res., 63, 2244–2250.
58. Loh,Y., Wu,Q., Chew,J., Vega,V.B., Zhang,W., Chen,X.,
Bourque,G., George,J., Leong,B., Liu,J. et al. (2006) The Oct4
and Nanog transcription network regulates pluripotency in mouse
embryonic stem cells. Nat. Genet., 38, 431–440.
59. Yi,F. and Merrill,B.J. (2007) Stem cells and TCF proteins: a role
for beta-catenin-independent functions. Stem Cell Rev., 3, 39–48.
60. Phillips,J.E. and Corces,V.G. (2009) CTCF: master weaver of the
genome. Cell, 137, 1194–1211.
61. McKay,M.J., Troelstra,C., vander,P., Kanaar,R., Smit,B.,
Hagemeijer,A., Bootsma,D. and Hoeijmakers,J.H. (1996)
Sequence conservation of therad21 Schizosaccharomyces
pombeDNA double-strand break repair gene in human and
mouse. Genomics, 36, 305–315.
62. Wendt,K.S., Yoshida,K., Itoh,T., Bando,M., Koch,B.,
Schirghuber,E., Tsutsumi,S., Nagae,G., Ishihara,K., Mishiro,T.
et al. (2008) Cohesin mediates transcriptional insulation by CCCT
C-binding factor. Nature, 451, 796–801.
63. Rubio,E.D., Reiss,D.J., Welcsh,P.L., Disteche,C.M.,
Filippova,G.N., Baliga,N.S., Aebersold,R., Ranish,J.A. and
Krumm,A. (2008) CTCF physically links cohesin to chromatin.
Proc. Natl Acad. Sci. USA, 105, 8309–8314.
64. Jelinic,P., Stehle,J. and Shaw,P. (2006) The testis-speciﬁc
factor CTCFL cooperates with the protein methyltransferase
PRMT7 in H19 imprinting control region methylation.
PLoS Biol., 4, e355.
65. Bischof,L.J., Kagawa,N., Moskow,J.J., Takahashi,Y.,
Iwamatsu,A., Buchberg,A.M. and Waterman,M.R. (1998)
Members of the Meis1 and Pbx homeodomain protein families
cooperatively bind a cAMP-responsive sequence (CRS1) from
BovineCYP17. J. Biol. Chem., 273, 7941–7948.
66. Kappel,A., Schlaeger,T.M., Flamme,I., Orkin,S.H., Risau,W. and
Breier,G. (2000) Role of SCL/Tal-1, GATA, and ets transcription
factor binding sites for the regulation of ﬂk-1 expression during
murine vascular development. Blood, 96, 3078–3085.
67. Mouthon,M.A., Bernard,O., Mitjavila,M.T., Romeo,P.H.,
Vainchenker,W. and Mathieu-Mahul,D. (1993) Expression of tal-1
and GATA-binding proteins during human hematopoiesis. Blood,
81, 647–655.
68. Chan,H.M. and La Thangue,N.B. (2001) p300/CBP proteins:
HATs for transcriptional bridges and scaffolds. J. Cell Sci., 114,
2363–2373.
69. Visel,A., Blow,M.J., Li,Z., Zhang,T., Akiyama,J.A., Holt,A.,
Plajzer-Frick,I., Shoukry,M., Wright,C., Chen,F. et al. (2009)
ChIP-seq accurately predicts tissue-speciﬁc activity of enhancers.
Nature, 457, 854–858.
70. Costa,R.H., Kalinichenko,V.V., Holterman,A.L. and Wang,X.
(2003) Transcription factors in liver development, differentiation,
and regeneration. Hepatology, 38, 1331–1347.
71. Zaret,K.S. and Carroll,J.S. (2011) Pioneer transcription factors:
establishing competence for gene expression. Genes Dev., 25,
2227–2241.
72. Johnson,C.A. and Turner,B.M. (1999) Histone deacetylases:
complex transducers of nuclear signals. Semin. Cell Dev. Biol., 10,
179–188.
73. Furusawa,T. and Cherukuri,S. (2010) Developmental function of
HMGN proteins. Biochim. Biophys. Acta, 1799, 69–73.
74. Peng,J., Zhu,Y., Milton,J.T. and Price,D.H. (1998) Identiﬁcation
of multiple cyclin subunits of human P-TEFb. Genes Dev., 12,
755–762.
75. Partington,G.A. and Patient,R.K. (1999) Phosphorylation of
GATA-1 increases its DNA-binding afﬁnity and is correlated with
induction of human K562 erythroleukaemia cells. Nucleic Acids
Res., 27, 1168–1175.
76. Ernst,J., Kheradpour,P., Mikkelsen,T.S., Shoresh,N., Ward,L.D.,
Epstein,C.B., Zhang,X., Wang,L., Issner,R., Coyne,M. et al.
(2011) Mapping and analysis of chromatin state dynamics in nine
human cell types. Nature, 473, 43–49.
77. Xu,D., Zhao,L., Del Valle,L., Miklossy,J. and Zhang,L. (2008)
Interferon regulatory factor 4 is involved in Epstein-Barr virus-
mediated transformation of human B lymphocytes. J. Virol., 82,
6251–6258.
78. Paun,A. and Pitha,P.M. (2007) The IRF family, revisited.
Biochimie, 89, 744–753.
79. Corcoran,L.M., Karvelas,M., Nossal,G.J., Ye,Z.S., Jacks,T. and
Baltimore,D. (1993) Oct-2, although not required for early B-cell
development, is critical for later B-cell maturation and for
postnatal survival. Genes Dev., 7, 570–582.
80. Baeuerle,P.A. and Henkel,T. (1994) Function and activation of
NF-kappa B in the immune system. Annu. Rev. Immunol., 12,
141–179.
81. Lee,C.S., Friedman,J.R., Fulmer,J.T. and Kaestner,K.H. (2005)
The initiation of liver development is dependent on Foxa
transcription factors. Nature, 435, 944–947.
82. Seto,E., Shi,Y. and Shenk,T. (1991) YY1 is an initiator sequence-
binding protein that directs and activates transcription in vitro.
Nature, 354, 241–245.
83. Nagarajan,P., Onami,T.M., Rajagopalan,S., Kania,S., Donnell,R.
and Venkatachalam,S. (2009) Role of chromodomain helicase
DNA-binding protein 2 in DNA damage response signaling and
tumorigenesis. Oncogene, 28, 1053–1062.
Nucleic Acids Research, 2013 11
 at M
IT Libraries on February 12, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
84. Deng,C. (2003) Roles of BRCA1 in DNA damage repair: a link
between development and cancer. Hum. Mol. Genet., 12,
113R–123R.
85. Xie,X., Lu,J., Kulbokas,E.J., Golub,T.R., Mootha,V., Lindblad-
Toh,K., Lander,E.S. and Kellis,M. (2005) Systematic discovery of
regulatory motifs in human promoters and 3[prime] UTRs by
comparison of several mammals. Nature, 434, 338–345.
86. Farnham,P.J. (2009) Insights from genomic proﬁling of
transcription factors. Nat. Rev. Genet., 10, 605–616.
87. Landt,S.G., Marinov,G.K., Kundaje,A., Kheradpour,P., Pauli,F.,
Batzoglou,S., Bernstein,B.E., Bickel,P., Brown,J.B., Cayting,P.
et al. (2012) ChIP-seq guidelines and practices of the ENCODE
and modENCODE consortia. Genome Res., 22, 1813–1831.
88. Spivakov,M., Akhtar,J., Kheradpour,P., Beal,K., Girardot,C.,
Koscielny,G., Herrero,J., Kellis,M., Furlong,E.E. and Birney,E.
(2012) Analysis of variation at transcription factor binding sites
in Drosophila and humans. Genome Biol., 13, R49.
89. Ward,L.D. and Kellis,M. (2011) HaploReg: a resource for
exploring chromatin states, conservation, and regulatory motif
alterations within sets of genetically linked variants. Nucleic Acids
Res., 40, D930–D934.
90. Wang,J., Zhuang,J., Iyer,S., Lin,X., Whitﬁeld,T.W., Greven,M.C.,
Pierce,B.G., Dong,X., Kundaje,A., Cheng,Y. et al. (2012)
Sequence features and chromatin structure around the genomic
regions bound by 119 human transcription factors. Genome Res.,
22, 1798–1812.
91. Neph,S., Vierstra,J., Stergachis,A.B., Reynolds,A.P., Haugen,E.,
Vernot,B., Thurman,R.E., John,S., Sandstrom,R., Johnson,A.K.
et al. (2012) An expansive human regulatory lexicon encoded in
transcription factor footprints. Nature, 489, 83–90.
92. Berman,B.P., Nibu,Y., Pfeiffer,B.D., Tomancak,P., Celniker,S.E.,
Levine,M., Rubin,G.M. and Eisen,M.B. (2002) Exploiting
transcription factor binding site clustering to identify
cis-regulatory modules involved in pattern formation in the
Drosophila genome. Proc. Natl Acad. Sci. USA, 99, 757–762.
93. Schroeder,M.D., Pearce,M., Fak,J., Fan,H., Unnerstall,U.,
Emberly,E., Rajewsky,N., Siggia,E.D. and Gaul,U. (2004)
Transcriptional control in the segmentation gene network of
Drosophila. PLoS Biol., 2, e271.
94. Kellis,M., Patterson,N., Endrizzi,M., Birren,B. and Lander,E.S.
(2003) Sequencing and comparison of yeast species to identify
genes and regulatory elements. Nature, 423, 241–254.
95. Moses,A., Chiang,D., Pollard,D., Iyer,V. and Eisen,M. (2004)
MONKEY: identifying conserved transcription-factor binding
sites in multiple alignments using a binding site-speciﬁc
evolutionary model. Genome Biol., 5, R98.
96. Kheradpour,P., Stark,A., Roy,S. and Kellis,M. (2007) Reliable
prediction of regulator targets using 12 Drosophila genomes.
Genome Res., 17, 1919–1931.
97. Lindblad-Toh,K., Garber,M., Zuk,O., Lin,M.F., Parker,B.J.,
Washietl,S., Kheradpour,P., Ernst,J., Jordan,G., Mauceli,E. et al.
(2011) A high-resolution map of human evolutionary constraint
using 29 mammals. Nature, 478, 476–482.
98. Schmidt,D., Wilson,M.D., Ballester,B., Schwalie,P.C.,
Brown,G.D., Marshall,A., Kutter,C., Watt,S.,
Martinez-Jimenez,C.P. et al. (2010) Five-vertebrate ChIP-seq
Reveals the evolutionary dynamics of transcription factor
binding. Science, 328, 1036–1040.
99. Boyer,L.A., Lee,T.I., Cole,M.F., Johnstone,S.E., Levine,S.S.,
Zucker,J.P., Guenther,M.G., Kumar,R.M., Murray,H.L.,
Jenner,R.G. et al. (2005) Core transcriptional regulatory circuitry
in human embryonic stem cells. Cell, 122, 947–956.
100. Lee,T.I., Jenner,R.G., Boyer,L.A., Guenther,M.G., Levine,S.S.,
Kumar,R.M., Chevalier,B., Johnstone,S.E., Cole,M.F.,
Isono,K.I. et al. (2006) Control of developmental
regulators by polycomb in human embryonic stem cells. Cell,
125, 301–313.
101. MacArthur,S., Li,X., Li,J., Brown,J., Chu,H.C., Zeng,L.,
Grondona,B., Hechmer,A., Simirenko,L., Keranen,S. et al.
(2009) Developmental roles of 21 Drosophila transcription
factors are determined by quantitative differences in binding to
an overlapping set of thousands of genomic regions. Genome
Biol., 10, R80.
102. Pietrokovski,S. (1996) Searching databases of conserved sequence
regions by aligning protein multiple-alignments. Nucleic Acids
Res., 24, 3836–3845.
103. Gray,K.A., Daugherty,L.C., Gordon,S.M., Seal,R.L.,
Wright,M.W. and Bruford,E.A. (2013) Genenames.org:
the HGNC resources in 2013. Nucleic Acids Res., 41,
D545–D552.
104. Kharchenko,P.V., Tolstorukov,M.Y. and Park,P.J. (2008)
Design and analysis of ChIP-seq experiments for DNA-binding
proteins. Nat. Biotech., 26, 1351–1359.
105. Kent,W.J., Sugnet,C.W., Furey,T.S., Roskin,K.M., Pringle,T.H.,
Zahler,A.M. and Haussler,D. (2002) The human genome
browser at UCSC. Genome Res., 12, 996–1006.
106. Harrow,J., Frankish,A., Gonzalez,J.M., Tapanari,E.,
Diekhans,M., Kokocinski,F., Aken,B.L., Barrell,D., Zadissa,A.,
Searle,S. et al. (2012) GENCODE: The reference human genome
annotation for The ENCODE Project. Genome Res., 22,
1760–1774.
107. Touzet,H. and Varre,J. (2007) Efﬁcient and accurate P-value
computation for position weight matrices. Algorithms Mol. Biol.,
2, 15.
108. Wilson,E.B. (1927) Probable Inference, the Law of Succession,
and Statistical Inference. J. Am. Stat. Assoc., 22, 209–212.
109. Mahony,S., Auron,P.E. and Benos,P.V. (2007) DNA familial
binding proﬁles made easy: comparison of various motif
alignment and clustering strategies. PLoS Comput. Biol., 3, e61.
110. Sandelin,A. and Wasserman,W.W. (2004) Constrained
binding site diversity within families of transcription factors
enhances pattern discovery bioinformatics. J. Mol. Biol., 338,
207–215.
12 Nucleic Acids Research, 2013
 at M
IT Libraries on February 12, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
